February 3 2020, David R Brown
Azelis strengthens its market presence in India with the acquisition of S. Zhaveri Pharmakem's distribution business
Azelis, a leading distributor of specialty chemicals and food ingredients, has announced it is to acquire 100% of the distribution and Indent business of S. Zhaveri Pharmakem Pvt. Ltd. ("S. Zhaveri"), an Indian specialty distributor for the pharmaceutical industry. Founded in 1951 and headquartered in Mumbai, the company serves a number of reputable international and domestic principals. S. Zhaveri is 100% owned by the Javeri family and all its employees in the distribution business will become part of Azelis. The company serves more than 250 customers.
Establishing a strong presence in the pharmaceutical market in India is therefore essential for a distributor like Azelis and we are very excited to have found such a good partnerLaurent Nataf
CEO & President, Azelis Asia Pacific
The acquisition of S. Zhaveri's distribution business significantly increases Azelis India's footprint in the fast-growing Indian pharmaceutical market. As one of the largest producers of pharmaceuticals in the world, and with a strong growth trajectory, India is very important for Azelis' pharma expansion in the region and globally.
Mr. Laurent Nataf, CEO & President, Azelis Asia Pacific, explained: “The Indian pharmaceutical industry has grown dramatically over the last 20 years, making it one of the most established exporters of pharmaceuticals, particularly generics. This growth is projected to continue both domestically and internationally. Establishing a strong presence in the pharmaceutical market in India is therefore essential for a distributor like Azelis and we are very excited to have found such a good partner, which will serve as a good platform to further expand our pharma activities in India.”
Ms. Uma Javeri, Managing Director, at S. Zhaveri, added: “Becoming part of such a reputable and big international player will not only provide continuity and security of our distribution business but also additional expertise, infrastructure and growth opportunities.”
Ms. Aparna Khurana, Managing Director Azelis India, commented: “We expect that the addition of S. Zhaveri will help us strengthen our relationship with some of our strategic principals and open up many new opportunities.”
Azelis has been active in India since 2008 and operates application laboratories for Food, Personal Care and CASE in the country. The closing of the transaction is expected within the next few weeks. Following the closing, both Mrs. Uma Javeri and Ms. Sonali Sheth will support the integration of S. Zhaveri Pharmakem's distribution business and will lead the entire pharmaceutical business of Azelis in India.
Azelis is a leading distributor of speciality chemicals and food ingredients present in over 40 countries across the globe with around 2,000 employees. Our knowledgeable teams of industry, market and technical experts are each dedicated to a specific market within Life Sciences and Industrial Chemicals. We offer a lateral value chain of complementary products to about 40,000 customers, creating a turnover of €1.94 billion (2018). In the US we operate under a number of renowned co-brands in the personal care market segment.
Source(s): Azelis Press Release